PETQ - ペットIQ （PetIQ Inc.） ペットIQPETQのチャート
PETQの企業情報
| symbol | PETQ |
|---|---|
| 会社名 | PetIQ Inc （ペットIQ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Other Pharmaceuticals |
| 業種 | 小売_その他専門 一般消費財（Consumer Products） |
| 概要 | 事業概要 ペットIQ(PetIQ Inc.)は米国の小売チャネルにペット用医薬品と健康及びウェルネス製品の製造・販売に従事する。同社は、「Frontline Plus」、「Heartgard Plus」、「PetAction Plus」、「Advecta II」、「Pet Lock Plus」、「Pet Lock Max」、「TruProfen」、「Heartshield」などのサードパーティブランドを小売店に提供する。同社は獣医師、小売業者、電子商取引の各チャンネルを通じて製品を販売する。同社は、Rx医薬品、OTC医薬品および消耗品、健康および健康製品を含む各カテゴリーの製品を提供する。Rx医薬品には、ハートウォームの予防薬、関節炎、甲状腺、糖尿病と痛みの治療、抗生物質やその他の特殊医薬品が含まれる。同社は犬のハートウォーム感染を防止するハートガードプラスのハートシールドプラスを製造する。同社はまた、イヌの関節炎を治療するリマジルのバージョンであるTruProfenを製造している。OTCの医薬品には、ノミおよびダニのコントロール製品が含まれる。 ペットIQは米国のペット用医薬品企業。ペット用の処方箋医薬品、一般医薬品、ノミ・ダニ予防薬、健康・ウェルネス製品の製造・販売・代理販売に従事する。同社ブランドには「Heart Shield」、「Profen」、「Pet Action」、「VetIQ」など。同社の流通ブランドには「Frontline」や「Heartgard」を含む。本社はアイダホ州。 PetIQ is a leading pet medication and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable veterinary products and services. The company engages with customers through more than 60,000 points of distribution across retail and e-commerce channels with its branded and distributed medications, which is further supported by its own world-class medications manufacturing facility in Omaha, Nebraska. The company's national service platform, VIP Petcare, operates in over 3,400 retail partner locations in 41 states providing cost effective and convenient veterinary wellness services. PetIQ believes that pets are an important part of the family and deserve the best products and care. |
| 本社所在地 | 923 S. Bridgeway Pl. Eagle ID 83616 USA |
| 代表者氏名 | McCord Christensen マッコードクリステンセン |
| 代表者役職名 | Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者 |
| 電話番号 | +1 208-939-8900 |
| 設立年月日 | 42401 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2017年 |
| 従業員数 | 225人 |
| url | www.petiq.com |
| nasdaq_url | https://www.nasdaq.com/symbol/petq |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 18.02600 |
| 終値（lastsale） | 34.31 |
| 時価総額（marketcap） | 952674241.84 |
| 時価総額 | 時価総額（百万ドル） 931.29390 |
| 売上高 | 売上高（百万ドル） 398.68800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 130.7049 |
| 当期純利益 | 当期純利益（百万ドル） 0.57800 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 PetIQ Inc revenues increased 86% to $286.2M. Net income increased from $0K to $471K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items totaled to $0.02. |
PETQのテクニカル分析
PETQのニュース
PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023 2023/04/18 20:30:00 GlobeNewswire
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.
PetIQ Is A Bet On Steady Trends (NASDAQ:PETQ) 2023/03/11 12:33:26 Seeking Alpha
PetIQ is a company operating in a very large market, the pet care and health industry. Read more about PETQ here.
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday''s Mid-Day Session 2023/03/01 18:16:45 Benzinga
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.
PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results 2023/02/28 21:05:00 GlobeNewswire
Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook
Earnings Preview For PetIQ 2023/02/27 19:02:40 Benzinga
PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com
PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023 2023/04/18 20:30:00 GlobeNewswire
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.
PetIQ Is A Bet On Steady Trends (NASDAQ:PETQ) 2023/03/11 12:33:26 Seeking Alpha
PetIQ is a company operating in a very large market, the pet care and health industry. Read more about PETQ here.
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday''s Mid-Day Session 2023/03/01 18:16:45 Benzinga
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.
PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results 2023/02/28 21:05:00 GlobeNewswire
Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook
Earnings Preview For PetIQ 2023/02/27 19:02:40 Benzinga
PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday''s Mid-Day Session 2023/03/01 18:16:45 Benzinga
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.
PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results 2023/02/28 21:05:00 GlobeNewswire
Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook
Earnings Preview For PetIQ 2023/02/27 19:02:40 Benzinga
PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com
PetIQ, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023 2023/01/31 21:05:00 GlobeNewswire
EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close.